Search research articles
Contact Us
Filters
Showing results (101-110 of 122) with videos related to
Page
of 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 14, 2008
HER3 is a determinant for poor prognosis in melanoma
Markus Reschke, Daniela Mihic-Probst, Edward Htun van der Horst, et al.
Cancer Research
|
June 18, 2002
A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis
M Llanos Casanova, Fernando Larcher, Benito Casanova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 4, 2008
Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme
Markus Hutterer, Pjotr Knyazev, Ariane Abate, et al.
Journal of Hepatology
|
November 15, 2008
Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention
Han Kiat Ho, Sharon Pok, Sylvia Streit, et al.
The Journal of Biological Chemistry
|
August 5, 2004
Mammary gland remodeling depends on gp130 signaling through Stat3 and MAPK
Ling Zhao, Stefan Hart, JrGang Cheng, et al.
Molecular Oncology
|
May 21, 2014
Benzylidene-indolinones are effective as multi-targeted kinase inhibitor therapeutics against hepatocellular carcinoma
Han Kiat Ho, Boon Tin Chua, Winnie Wong, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 6, 2006
Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival
Peter Vajkoczy, Pjotr Knyazev, Andrea Kunkel, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery and Biological Evaluation of Novel Dual EGFR/c-Met Inhibitors
Bálint Szokol, Pál Gyulavári, Ibolya Kurkó, et al.
Cell Metabolism
|
June 11, 2013
The cancer-associated FGFR4-G388R polymorphism enhances pancreatic insulin secretion and modifies the risk of diabetes
Shereen Ezzat, Lei Zheng, Jose C Florez, et al.
Cancer Research
|
August 3, 2005
Proteomic characterization of the angiogenesis inhibitor SU6668 reveals multiple impacts on cellular kinase signaling
Klaus Godl, Oliver J Gruss, Jan Eickhoff, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 122) with videos related to
Sort By:
Page
of 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 14, 2008
HER3 is a determinant for poor prognosis in melanoma
Markus Reschke, Daniela Mihic-Probst, Edward Htun van der Horst, et al.
Cancer Research
|
June 18, 2002
A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis
M Llanos Casanova, Fernando Larcher, Benito Casanova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 4, 2008
Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme
Markus Hutterer, Pjotr Knyazev, Ariane Abate, et al.
Journal of Hepatology
|
November 15, 2008
Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention
Han Kiat Ho, Sharon Pok, Sylvia Streit, et al.
The Journal of Biological Chemistry
|
August 5, 2004
Mammary gland remodeling depends on gp130 signaling through Stat3 and MAPK
Ling Zhao, Stefan Hart, JrGang Cheng, et al.
Molecular Oncology
|
May 21, 2014
Benzylidene-indolinones are effective as multi-targeted kinase inhibitor therapeutics against hepatocellular carcinoma
Han Kiat Ho, Boon Tin Chua, Winnie Wong, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 6, 2006
Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival
Peter Vajkoczy, Pjotr Knyazev, Andrea Kunkel, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery and Biological Evaluation of Novel Dual EGFR/c-Met Inhibitors
Bálint Szokol, Pál Gyulavári, Ibolya Kurkó, et al.
Cell Metabolism
|
June 11, 2013
The cancer-associated FGFR4-G388R polymorphism enhances pancreatic insulin secretion and modifies the risk of diabetes
Shereen Ezzat, Lei Zheng, Jose C Florez, et al.
Cancer Research
|
August 3, 2005
Proteomic characterization of the angiogenesis inhibitor SU6668 reveals multiple impacts on cellular kinase signaling
Klaus Godl, Oliver J Gruss, Jan Eickhoff, et al.
Page
of 13